Indianapolis-based pharmaceutical giant Eli Lilly and Co. has tapped Anat Hakim to be its next general counsel. Hakim, who starts next week, will succeeds Michael Harrington, who’s retiring as of Friday. Hakim comes to
GRAIL, Inc., a healthcare company that says its mission to detect curable cancer early via blood-based DNA testing, hired Marissa Song as its general counsel and secretary. Song comes from Gilead Sciences, where she spent
Healthcare
High Tech and Biotech
News
Cancer biotech company Sesen promotes longtime biosciences lawyer Sullivan to
Sesen Bio, a late-stage clinical company developing fusion protein therapeutics for cancer treatment , promoted it deputy general counsel, Mark Sullivan, to be its general counsel and secretary. Sullivan (in the photo above) has more than
One of the biggest Big Pharma companies will be shopping for a new general counsel. The company is Eli Lillly and Co., and its current GC, Mike Harrington, announced that he’ll be retiring at
Cantel Medical Corp. says that Eric Nodiff, its general counsel, will retire at the end of the month 32 years of service to the company. Jeff Mann, his deputy in the photo above, has been promoted
Roger George, Align Technology‘s senior vice president, chief legal and regulatory officer has retired and will leave the company at the end of August 2019. George was responsible for all aspects of the dental equipment
Biotech medicines developer Beam Therapeutics, based in Cambridge, Massachusetts, has a new chief legal officer, Christine Bellon. The small company specializes in medicines that edit a patient’s DNA. Bellon has more than 25 years of
Spero Health, a Nashville, Tennessee-based organization that specializes in outpatient care for individuals suffering from substance use disorders, has hired Clint Cromwell to be its chief legal officer. According to the privately held Spero, Cromwell
Mauro Del Noce (in the photo above) will assume the role of general counsel Europe for the European region of Mindray Medical, a healthcare and high-tech medical devices multinational, reported our colleagues at inhousecommunity.it.
Neurotrope Inc., a clinical-stage biopharmaceutical company that’s developing therapies for such neurodegenerative diseases as Alzheimer’s disease, hired Michael Ciraolo as general counsel and chief operating officer. Ciraolo was most recently at Ovid Therapeutics,
